Mathias Schmid

3.8k citations

86 papers · 2.0k indexed · h-index 24

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
Genetics top 1%
- Hemoglobinopathies and Related Disorders
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in ⓘ

Genetics 32
- Chronic Lymphocytic Leukemia Research 15
- Hemoglobinopathies and Related Disorders 13
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
Hematology 28
- Acute Myeloid Leukemia Research 22

Co-authors: Hartmut Döhner (11 shared papers)Franz Porzsolt (8 shared papers)Dennis A. Carson (3 shared papers)Andrea Kuendgen (2 shared papers)Norbert Gattermann (8 shared papers)Matteo Giovanni Della Porta (10 shared papers)Pierre Fenaux (6 shared papers)Richard F. Schlenk (5 shared papers)
Journals: Blood (23 papers)Journal of Clinical Oncology (6 papers)Leukemia Research (5 papers)Haematologica (3 papers)British Journal of Haematology (2 papers)
Partner nations: Germany Switzerland United States

In The Last Decade

Mathias Schmid

81 papers receiving 2.0k citations

Peers

Countries citing papers authored by Mathias Schmid

Since Specialization

Citations

This map shows the geographic impact of Mathias Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Schmid more than expected).

Fields of papers citing papers by Mathias Schmid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Schmid. The network helps show where Mathias Schmid may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathias Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathias Schmid Line = papers co-authored together Mathias Schmid links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia Cancer ·Andrea Kuendgen, Mathias Schmid, Richard F. Schlenk, Sabine Knipp, Barbara Hildebrandt, Christian Steidl, Ulrich Germing, Rainer Haas, Hartmut Döhner, Norbert Gattermann	2005	188
2	A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy Haematologica ·Michael Lübbert, Björn Rüter, Rainer Claus, Claudia Schmoor, Mathias Schmid, Ulrich Germing, Andrea Kuendgen, Volker Rethwisch, Arnold Ganser, Uwe Platzbecker, Oliver Galm, Wolfram Brugger, Gerhard Heil, Björn Hackanson, Barbara Deschler-Baier, Konstanze Döhner, A Hagemeijer, P. Wijermans, Hartmut Döhner	2011	172
3	Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study Leukemia Research ·Norbert Gattermann, Carlo Finelli, Matteo Giovanni Della Porta, Pierre Fenaux, Arnold Ganser, Agnès Guerci‐Bresler, Mathias Schmid, Kerry Taylor, (unknown), Sy Ha, Gabor Domokos, Bernard Roubert, Christian Rosé	2010	138
4	Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes Haematologica ·N. Gattermann, Carlo Finelli, Matteo Giovanni Della Porta, Pierre Fenaux, Michael Stadler, A. Guerci-Bresler, Mathias Schmid, K Taylor, (unknown), Dany Habr, Andrea Marcellari, Bernard Roubert, Christian Rose	2012	124
5	Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC) Oncogene ·Mathias Schmid, Denise Malicki, Tsutomu Nobori, Michael Rosenbach, Katari Campbell, Dennis A. Carson, Carlos J. Carrera	1998	90
6	High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. Journal of Clinical Investigation ·W. Digel, Franz Porzsolt, Mathias Schmid, F. Herrmann, Werner Lesslauer, Manfred Brockhaus	1992	87
7	Molecular Genetic Alterations in Radiation-Induced Astrocytomas American Journal Of Pathology ·Daniel J. Brat, C. David James, Anne Jedlicka, Denise C. Connolly, Ed Chang, Rudy J. Castellani, Mathias Schmid, Martin R. Schiller, Dennis A. Carson, Peter C. Burger	1999	85
8	Protein Kinase D2 Mediates Activation of Nuclear Factor κB by Bcr-Abl in Bcr-Abl+ Human Myeloid Leukemia Cells Cancer Research ·Tamara Mihailovic, Martin B. Marx, Alexandra Auer, Johan Van Lint, Mathias Schmid, Christoph K. Weber, Thomas Seufferlein	2004	71
9	Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003 Blood ·Dieter Hoelzer, Andreas Huettmann, Felix Kaul, Sebastian Irmer, Nadja Jaekel, Martin Mohren, Thomas Lipp, Knut Wedelin, F. De Valle, Mathias Schmid, Eckhard Thiel, Monika Brüggemann, Michael Kneba, Nicola Goekbuget	2010	67
10	Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation Blood ·H. Heimpel, Klaus Schwarz, Monika Ebnöther, Jeroen S. Goede, D. Heydrich, Torsten Kamp, Lothar Plaumann, Bettina Rath, Jochen Roessler, O Schildknecht, Mathias Schmid, Walter A. Wuillemin, Beate Einsiedler, Rosi Leichtle, Hannah Tamary, E. Kohne	2005	63
11	Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in chronic lymphocytic leukaemia British Journal of Haematology ·Judit Demeter, Franz Porzsolt, Stephanie Rämisch, Dorothee Schmidt, Mathias Schmid, Gerald Messer	1997	59
12	CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q. PubMed ·Peter Liebisch, Susanne Eppinger, Christine Schöpflin, G. Stehle, Gerd Munzert, Hartmut Döhner, Mathias Schmid	2005	53
13	Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma Haematologica ·Nicola Gökbuget, Christine-Maria Hartog, Renato Bassan, Hans Guenter Derigs, Hervé Dombret, R. Greil, Jesús María Hernández‐Rivas, F. Huguet, Tamara Intermesoli, Éric Jourdan, Christian Junghanß, Lothar Leimer, M.-J. Moreno, Albrecht Reichle, Josep‐María Ribera, Mathias Schmid, Hubert Serve, M. Stelljes, Reingard Stuhlmann, D. Hoelzer	2010	44
14	A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer Oncogene ·Mathias Schmid, Malini Sen, Michael Rosenbach, Carlos J. Carrera, Henry S. Friedman, Dennis A. Carson	2000	43
15	PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003 Blood ·Nicola Goekbuget, Anja Baumann, Joachim Beck, Monika Brüggemann, H. Diedrich, Andreas Huettmann, Lothar Leimer, Stefan Zewen, Martin Mohren, Albrecht Reichle, Markus Schaich, Kerstin Schaefer‐Eckart, Marc Schmalzing, Mathias Schmid, Hubert Serve, Reingard Stuhlmann, Theis H. Terwey, Dieter Hoelzer	2010	43
16	Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer European Radiology ·Agnieszka Konieczny, Philipp T. Meyer, Annelies Schnider, Paul Komminoth, Mathias Schmid, Norbert Lombriser, Dominik Weishaupt	2013	30
17	Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. PubMed ·Judit Demeter, Gerald Messer, Stephanie Rämisch, John Mee, Francesco S. di Giovine, Mathias Schmid, F. Herrmann, Franz Porzsolt	1996	27
18	P53 mutations in hairy cell leukemia Leukemia ·König Ea, WC Kusser, Corbin Day, Franz Porzsolt, B.W. Glickman, Gerald Messer, Mathias Schmid, R Châtel, ZL Marcsek, Judit Demeter	2000	27
19	Altered Sensitivity to Retinoid-Induced Apoptosis Associated with Changes in the Subcellular Distribution of Bcl-2 Experimental Cell Research ·Arlette Bruel, E. Karsenty, Mathias Schmid, Timothy J. McDonnell, Michel Lanotte	1997	25
20	Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networks Epigenetics ·Frank G. Rücker, K. Lang, Markus Fütterer, Vladimir Komarica, Mathias Schmid, Hartmut Döhner, Richard F. Schlenk, Konstanze Döhner, Steen Knudsen, Lars Bullinger	2016	25

About Mathias Schmid

Mathias Schmid is a scholar working on Genetics, Hematology, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 86 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Chronic Lymphocytic Leukemia Research (15 papers), Hemoglobinopathies and Related Disorders (13 papers), Acute Lymphoblastic Leukemia research (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Histone Deacetylase Inhibitors Research (7 papers) and Protein Degradation and Inhibitors (7 papers). The work is most often cited by research in Hematology (807 citations), Genetics (638 citations), Oncology (383 citations), Pathology and Forensic Medicine (216 citations) and Immunology (233 citations). Mathias Schmid has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Hartmut Döhner, Franz Porzsolt, Dennis A. Carson, Andrea Kuendgen, Norbert Gattermann, Matteo Giovanni Della Porta, Pierre Fenaux, Richard F. Schlenk, Arnold Ganser and Bernard Roubert. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Haematologica and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact